Mogamulizumab-kpkc Intravenous and Prograf (Tacrolimus Granules for Suspension)
Determining the interaction of Mogamulizumab-kpkc Intravenous and Prograf (Tacrolimus Granules for Suspension) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: tacrolimus
Brand name: Prograf, Astagraf XL, Envarsus XR, Hecoria
Synonyms: Prograf
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Prograf (Tacrolimus Injection)
- Mogamulizumab-kpkc Intravenous-Prograf Intravenous
- Mogamulizumab-kpkc Intravenous-Prohance
- Mogamulizumab-kpkc Intravenous-ProHance Injection
- Mogamulizumab-kpkc Intravenous-Prohist LQ
- Mogamulizumab-kpkc Intravenous-Prolensa
- Prograf (Tacrolimus Granules for Suspension)-Molindone
- Prograf (Tacrolimus Granules for Suspension)-Mometasone (Oral Inhalation)
- Prograf (Tacrolimus Granules for Suspension)-Mometasone and Formoterol
- Prograf (Tacrolimus Granules for Suspension)-Mometasone and formoterol Inhalation
- Prograf (Tacrolimus Granules for Suspension)-Mometasone Cream
- Prograf (Tacrolimus Granules for Suspension)-Mometasone Furoate